- Home
- PRTA vs ARMN Comparison
PRTA vs ARMN Comparison
Compare PRTA & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ARMN
- Stock Information
- Founded
- PRTA 2012
- ARMN 1992
- Country
- PRTA Ireland
- ARMN Canada
- Employees
- PRTA N/A
- ARMN N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ARMN
- Sector
- PRTA Health Care
- ARMN
- Exchange
- PRTA Nasdaq
- ARMN Nasdaq
- Market Cap
- PRTA 809.8M
- ARMN 769.7M
- IPO Year
- PRTA N/A
- ARMN N/A
- Fundamental
- Price
- PRTA $9.70
- ARMN $5.39
- Analyst Decision
- PRTA Buy
- ARMN
- Analyst Count
- PRTA 9
- ARMN 0
- Target Price
- PRTA $54.57
- ARMN N/A
- AVG Volume (30 Days)
- PRTA 605.6K
- ARMN 1.4M
- Earning Date
- PRTA 05-07-2025
- ARMN 05-13-2025
- Dividend Yield
- PRTA N/A
- ARMN N/A
- EPS Growth
- PRTA N/A
- ARMN 77.15
- EPS
- PRTA N/A
- ARMN 0.14
- Revenue
- PRTA $135,157,000.00
- ARMN $510,604,000.00
- Revenue This Year
- PRTA N/A
- ARMN $49.45
- Revenue Next Year
- PRTA $131.71
- ARMN N/A
- P/E Ratio
- PRTA N/A
- ARMN $38.06
- Revenue Growth
- PRTA 47.92
- ARMN 14.06
- 52 Week Low
- PRTA $9.00
- ARMN $3.29
- 52 Week High
- PRTA $25.42
- ARMN $5.65
- Technical
- Relative Strength Index (RSI)
- PRTA 34.03
- ARMN 61.93
- Support Level
- PRTA $9.00
- ARMN $5.24
- Resistance Level
- PRTA $10.07
- ARMN $5.53
- Average True Range (ATR)
- PRTA 0.74
- ARMN 0.28
- MACD
- PRTA 0.07
- ARMN 0.01
- Stochastic Oscillator
- PRTA 28.00
- ARMN 76.64
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.